Epidemiology of Nasopharyngeal Carcinoma in Sarawak, East Malaysia.
NPC
epidemiology, Sarawak, Borneo
nasopharyngeal
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Aug 2023
01 Aug 2023
Historique:
received:
10
04
2023
medline:
31
8
2023
pubmed:
29
8
2023
entrez:
29
8
2023
Statut:
epublish
Résumé
This analysis provides an epidemiological update for nasopharyngeal carcinomas the state of Sarawak and an analysis of the trend over a 20 years period. Data between 1996 to 2015 from a population-based cancer registry in Sarawak Malaysia was analyzed. Crude incidence rates and age-standardized rates (ASR) were calculated and compared between ethnic groups and locations (administrative division) and Joinpoint regression analysis was done to analyze trends. A total of 3643 cases of NPC were recorded with male to female ratio of 2.5:1. Annualised age-standardized incidence rates able 2) for men is 13.2 cases per 100,000 population (95% CI: 12.6, 13.7) and for women is 5.3 cases per 100,000 population (95% CI: 5.0, 5.6). The highest incidence rates were reported among the Bidayuh population and it ranks among the highest in the world. Trend analysis noted an overall reduction of cases, with a significant decrease between 1996 and 2003 (annual percentage reduction of incidence by 3.9%). Analysis of individual ethnic groups also shows a general reduction with exception of Iban males showing an average 5.48 per cent case increase between 2009 to 2015, though not statistically significant. Comparing the incidences with other registries, the Bidayuh population in Sarawak remained among the highest in the world and warrants close attention for early screening and prevention strategies.
Identifiants
pubmed: 37642069
doi: 10.31557/APJCP.2023.24.8.2817
pmc: PMC10685242
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2817-2822Références
Oncol Lett. 2021 Jul;22(1):514
pubmed: 33986874
Lancet. 2019 Jul 6;394(10192):64-80
pubmed: 31178151
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):482-6
pubmed: 15006927
ORL J Otorhinolaryngol Relat Spec. 2021;83(4):258-262
pubmed: 34148048
Am J Public Health. 2000 May;90(5):695-8
pubmed: 10800415
Malays J Med Sci. 2021 Feb;28(1):66-74
pubmed: 33679222
Chin J Cancer. 2015 May 14;34(8):350-7
pubmed: 26058679
Front Genet. 2022 Jan 27;13:767018
pubmed: 35154269
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1765-77
pubmed: 17035381
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Jpn J Clin Oncol. 2013 Mar;43(3):219-24
pubmed: 23303840
Lancet. 2016 Mar 5;387(10022):1012-1024
pubmed: 26321262
Eur J Epidemiol. 2014 Aug;29(8):551-8
pubmed: 24407880
Chin J Cancer. 2017 Jan 7;36(1):3
pubmed: 28063457